THE 2-MINUTE RULE FOR SITUS JUDI MBL77

mutations presented the fact that, as discussed beneath, CLL therapy is predicated on the presence or absence of such mutations. The current consensus is, besides clonal mutations, subclonal mutations having a variant allelic frequency starting from 5 to 10% (and for that reason below the brink of detection by regular molecular procedures) is also